News
Shares of GSK fell to below $30 around the time of the demerger, but have since recovered to about $36. The 20% gain over 34 ...
GSK shares fell after a Food and Drug Administration advisory committee voted against approval of the company's Blenrep drug, a setback for its bid to reintroduce the blood-cancer treatment in the U.S ...
Discover how Obexelimab's unique B-cell inhibition and pivotal Phase 3 IgG4 results could drive Zenas BioPharma, Inc.'s ...
Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 3.3% in the morning session after the stock gained ...
The FTSE 100 has ticked up this morning after what became a wobbly session on Monday, with a stack of fresh earnings updates helping traders early on Tuesday. Entain and Games Workshop are leading ...
In May, biotech iTeos Therapeutics decided to close down after being abandoned by GSK over the disappointing mid-stage ...
StockStory.org on MSN7d
Why Privia Health (PRVA) Stock Is Up TodayShares of healthcare tech company Privia Health Group (NASDAQ:PRVA) jumped 3.4% in the morning session as investors ...
3h
Zacks Investment Research on MSNModerna to Report Q2 Earnings: Is a Beat in Store for the Stock?We expect Moderna MRNA to surpass expectations when it reports second-quarter 2025 earnings on Aug. 1, before the opening ...
Pakistan’s pharmaceutical sector stands as one of the steadily growing industries within the country’s economy.
At 1:08 p.m. ET (17:08 GMT), the Dow Jones Industrial Average rose 128 points, or 0.3%, the S&P 500 index gained 0.4%, and ...
StockStory.org on MSN6d
Why AMN Healthcare Services (AMN) Stock Is Trading Up TodayShares of healthcare staffing company AMN Healthcare Services (NYSE:AMN) jumped 6% in the afternoon session after Truist Securities reiterated its 'Buy' rating on the company. The Wall Street firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results